心臓　55/12　2023年12月号

出版社： 日本医学出版
発行日： 2023-12-15
分野： 臨床医学：内科  >  雑誌
ISSN： 05864488
雑誌名：
電子書籍版： 2023-12-15
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：4～8営業日

2,200 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

2,200 円(税込)

購入する

目次

  • Open HEART
    　知的好奇心と研究

    HEART’s Selection
    　循環器疾患とAI
    　1．レントゲンの新時代：AIが実臨床で拓く可能性
    　2．心電図AIの力：心電図AIが循環器診療を革新する
    　3．心エコーAIの挑戦：希少疾患検出への新たなアプローチ
    　4．虚血性心疾患診療の革新：AIが描くプレシジョンメディスンの可能性
    　5．循環器医の新たなパートナー：ChatGPTの活用法とその効用

    [連載]HEART's　Column
    Authorが語る日本発のクリニカル・エビデンス：論文の解説と発表後の展望
    　Long-term outcome of chronic thromboembolic pulmonary hypertension using direct oral
    　anticoagulants and warfarin：a Japanese prospective cohort study

    [連載]HEART’s Up To Date
    循環器医が知っておくべき最新のエビデンス

    HEART’s Original
    [症例]
    　三尖弁輪–下大静脈峡部ブロックの存在下に、通常型心房粗動に
    　　極めて酷似する心電図波形を呈した時計方向僧帽弁旋回性心房粗動の1例
    [症例]
    　乳癌に対する化学療法中に発症したG-CSF製剤による薬剤性血管炎の1例
    [Editorial Comment]
    　岩本論文に対するEditorial　Comment
    [症例]
    　魚骨による食道心嚢瘻から細菌性心膜炎に至った1例
    [Editorial Comment]
    　高柳論文に対するEditorial　Comment
    [症例]
    　特発性血小板減少性紫斑病を合併した非ST上昇型心筋梗塞患者に対して
    　　超短期DAPTで加療し良好な経過であった1例
    [Editorial Comment]
    　吉田論文に対するEditorial　Comment―出血ハイリスク（HBR）患者におけるDAPTの治療戦略
    [Editorial Comment]
    　吉田論文に対するEditorial　Comment
    [症例]
    　挙児希望のある連合弁膜症患者に生体弁による大動脈弁置換術と僧帽弁交連切開術を施行した1例

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

【HEART' s Selection】

P.1134 掲載の参考文献
1) Kusunose K : Steps to use artificial intelligence in echocardiography. J Echocardiogr 2021 ; 19 : 21-27
 
2) Kusunose K : Revolution of echocardiographic reporting : the new era of artificial intelligence and natural language processing. J Echocardiogr 2023 ; 21 : 99-104
 
3) Kusunose K, Hirata Y, Tsuji T, et al : Deep learning to predict elevated pulmonary artery pressure in patients with suspected pulmonary hypertension using standard chest X ray. Sci Rep 2020 ; 10 : 19311
PubMed
4) Hirata Y, Kusunose K, Tsuji T, et al : Deep Learning for Detection of Elevated Pulmonary Artery Wedge Pressure Using Standard Chest X-Ray. Can J Cardiol 2021 ; 37 : 1198-1206
 
5) Kusunose K, Hirata Y, Yamaguchi N, et al : Deep learning approach for analyzing chest x-rays to predict cardiac events in heart failure. Front Cardiovasc Med 2023 ; 10 : 1081628
PubMed
P.1138 掲載の参考文献
1) Lopez-Jimenez F, Attia Z, Arruda-Olson AM, et al : Artificial Intelligence in Cardiology : Present and Future. Mayo Clin Proc 2020 ; 95 : 1015-1039
 
2) Holzinger A, Langs G, Denk H, et al : Causability and explainability of artificial intelligence in medicine. Wiley Interdiscrip Rev Data Min Knowl Discov 2019 ; 9 : e1312
PubMed
3) Belle V, Papantonis I : Principles and Practice of Explainable Machine Learning. Front Big Data 2021 ; 4 : 688969
PubMed
4) Katsushika S, Kodera S, Nakamoto M, et al : The Effectiveness of a Deep Learning Model to Detect Left Ventricular Systolic Dysfunction from Electrocardiograms. Int Heart J 2021 ; 62 : 1332-1341
 
5) Selvaraju RR, Cogswell M, Das A, et al : Grad-CAM : Visual Explanations from Deep Networks via Gradient-based Localization. In : Proc IEEE Int Conf Comput Vis ; 2017, p.618-626
 
6) Lundberg SM, Allen PG, Lee S-I : A Unified Approach to Interpreting Model Predictions. In : Proc 31st Int Conf Neural Inf Process Syst, Long beach, California, USA : 2017, p.4765-4744
 
7) Katsushika S, Kodera S, Sawano S, et al : An explainable artificial intelligence-enabled electrocardiogram analysis model for the classification of reduced left ventricular function. Eur Heart J Digit Health 2023 ; 4 : 254-264
 
8) O'Neal WT, Mazur M, Bertoni AG, et al : Electrocardiographic predictors of heart failure with reduced versus preserved ejection fraction : The multi-ethnic study of atherosclerosis. J Am Heart Assoc 2017 ; 6 : e006023
PubMed
9) 小寺聡, 仁宮洸太, 澤野晋之介, ほか : 医療AIに対する患者の意識調査. 人工知能学会全国大会論文集 2022. doi : https://doi.org/10.11517/pjsai.JSAI2022.0_2K6OS1b04 (cited 2023 Oct 08)
 
P.1143 掲載の参考文献
1) Goto S, Goto S : Application of Neural Networks to 12-Lead Electrocardiography-Current Status and Future Directions-. Circ Rep 2019 ; 1 : 481-486
 
2) Goto S, McGuire DK, Goto S : The Future Role of High-Performance Computing in Cardiovascular Medicine and Science -Impact of Multi-Dimensional Data Analysis. J Atheroscler Thromb 2022 ; 29 : 559-562
 
3) Deo RC : Machine Learning in Medicine. Circulation 2015 ; 132 : 1920-1930
 
4) Shiraishi Y, Goto S, Niimi N, et al : Improved prediction of sudden cardiac death in patients with heart failure through digital processing of electrocardiography. Europace 2023 ; 25 : 922-930
 
5) Goto S, Goto S, Pieper KS, et al : New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists : GARFIELD-AF. Eur Heart J Cardiovasc Pharmacother 2019 ; 6 : 301-309
 
6) Miura K, Goto S, Katsumata Y, et al : Feasibility of the deep learning method for estimating the ventilatory threshold with electrocardiography data, NPJ Digit Med 2020 ; 3 : 141
PubMed
7) Goto S, Kimura M, Katsumata Y, et al : Artificial intelligence to predict needs for urgent revascularization from 12-leads electrocardiography in emergency patients, PLoS One 2019 ; 14 : e0210103
PubMed
8) Goto S, Ozawa H : The Importance of External Validation for Neural Network Models. JACC Advances 2023 ; 2 : 100610
 
9) Goto S, Mahara K, Beussink-Nelson L, et al : Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms and echocardiograms, Nat Commun 2021 ; 12 : 2726
PubMed
10) Goto S, Solanki D, John JE, et al : Multinational Federated Learning Approach to Train ECG and Echocardiogram Models for Hypertrophic Cardiomyopathy Detection. Circulation 2022 ; 146 : 755-769
 
11) Miura K, Yagi R, Miyama H, et al : Deep learning-based model detects atrial septal defects from electrocardiography : a cross-sectional multicenter hospital-based study, EClinicalMedicine 2023 ; 63 : 102141
PubMed
12) Yagi R, Goto S, Katsumata Y, et al : Importance of external validation and subgroup analysis of artificial intelligence in the detection of low ejection fraction from electrocardiograms, Eur Heart J Digit Health 2022 ; 3 : 654-657
 
P.1148 掲載の参考文献
1) Patel AP, Khera AV : Advances and Applications of Polygenic Scores for Coronary Artery Disease. Annu Rev Med 2023 ; 74 : 141-154
 
2) Khera AV, Emdin CA, Drake I, et al : Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. N Engl J Med 2016 ; 375 : 2349-2358
 
3) Mega JL, Stitziel NO, Smith JG, et al : Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy : an analysis of primary and secondary prevention trials. Lancet 2015 ; 385 : 2264-2271
 
4) Mujwara D, Henno G, Vernon ST, et al : Integrating a Polygenic Risk Score for Coronary Artery Disease as a Risk-Enhancing Factor in the Pooled Cohort Equation : A Cost-Effectiveness Analysis Study. J Am Heart Assoc 2022 ; 11 : e025236
PubMed
5) Theodoris CV, Xiao L, Chopra A, et al : Transfer learning enables predictions in network biology. Nature 2023 ; 618 : 616-624
 
6) Steinhubl SR, Waalen J, Edwards AM, et al : Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation : The mSToPS Randomized Clinical Trial. JAMA 2018 ; 320 : 146-155
 
7) Perez MV, Mahaffey KW, Hedlin H, et al : Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation. N Engl J Med 2019 ; 381 : 1909-1917
 
8) Al-Zaiti SS, Martin-Gill C, Zegre-Hemsey JK, et al : Machine learning for ECG diagnosis and risk stratification of occlusion myocardial infarction. Nat Med 2023 ; 29 : 1804-1813
 
9) Jiang LY, Liu XC, Nejatian NP, et al : Health system-scale language models are all-purpose prediction engines. Nature 2023 ; 619 : 357-362
 
10) Tu T, Azizi S, Driess D, et al : Towards generalist biomedical AI. arXiv preprint 2023 Jul 26 ; arXiv : 2307. 14334. doi : https://doi.org/10.48550/arXiv.2307.14334 (cited 2023 Oct 10)
 
P.1154 掲載の参考文献
1) Vaswani A, Shazeer N, Parmar N, et al : Attention is All you Need. Advances in Neural Information Processing Systems 30 (NIPS 2017)
 
2) Brown T, Mann B, Ryder N, et al : Language models are few-shot learners. Advances in Neural Information Processing Systems 33 (NeurIPS 2020)
 
3) Ouyang L, Wu J, Jiang X, et al : Training language models to follow instructions with human feedback. Advances in Neural Information Processing Systems 35 (NeurIPS 2022)
 
4) Kung TH, Cheatham M, Medenilla A, et al : Performance of ChatGPT on USMLE : Potential for AI-assisted medical education using large language models. PLOS Digit Health 2023 ; 2 : e0000198
PubMed
5) Tanaka Y, Nakata T, Aiga K, et al : Performance of Generative Pretrained Transformer on the National Medical Licensing Examination in Japan. medRxiv 2023.Apr.17. doi : https://doi.org/10.1101/2023.04.17.23288603 (cited 2023 Sep 23)
 
6) Doximity Inc. : DocsGPT. https://www.doximity.com/docs-gpt-info/ (cited 2023 Sep 23)
 
7) Glass Health : Glass AI. https://glass.health/ai/ (cited 2023 Sep 23)
 

【連載】

P.1157 掲載の参考文献
1) Hosokawa K, Abe K, Funakoshi K, Tamura Y, Nakashima N, Todaka K, Taniguchi Y, Inami T, Adachi S, Tsujino I, Yamashita J, Minatsuki S, Ikeda N, Shimokawahara H, Kawakami T, Ogo T, Hatano M, Ogino H, Fukumoto Y, Tanabe N, Matsubara H, Fukuda K, Tatsumi K, Tsutsui H : Long-term outcome of chronic thromboembolic pulmonary hypertension using direct oral anticoagulants and warfarin : a Japanese prospective cohort study. J Thromb Haemost 2023 ; 21 : 2151-2162
 
2) Mizoguchi H, Ogawa A, Munemasa M, et al : Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 2012 ; 5 : 748-755
 
3) Humbert M, Simonneau G, Pittrow D, et al : Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant 2022 ; 41 : 716-721
 
4) Bunclark K, Newnham M, Chiu YD, et al : A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension. J Thromb Haemost 2020 ; 18 : 114-122
 
5) Hosokawa K, Abe K, Kishimoto J, et al : Efficacy and safety of edoxaban in patients with chronic thromboembolic pulmonary hypertension : protocol for a multicentre, randomised, warfarin-controlled, parallel group trial-KABUKI trial. BMJ Open 2022 ; 12 : e061225
PubMed
6) Hosokawa K, Watanabe H, Taniguchi Y, et al : A multicenter, single-blind, randomized, warfarin-controlled trial of edoxaban in patients with chronic thromboembolic pulmonary hypertension : KABUKI trial. Circulation 2023 Nov 13. doi : 10.1161/CIRCULATIONAHA.123.067528. [Online ahead of print]
 

【HEART' s Original】

P.1167 掲載の参考文献
1) Bun SS, Latcu DG, Marchlinski F, Saoudi N : Atrial Flutter : more than just one of a kind. Eur Heart J 2015 : 36 : 2356-2363
 
2) Sasaki K, Sasaki S, Kimura M, et al : Revisit of typical counterclockwise atrial flutter wave in the ECG : electroanatomic studies on the determinants of the morphology. Pacing Clin Electrophysiol 2013 ; 36 : 978-987
 
3) Milliez P, Richardson AW, Obioha-Ngwu O, et al : Variable electrocardiographic characteristics of isthmusdependent atrial flutter. J Am Coll Cardiol 2002 ; 40 : 1125-1132
 
4) Hu W, Zhou D, Hua B, et al : Flutter Wave Morphology of Peri-Mitral Atrial Flutters Is Mainly Determined by Right Atrial Activation : Insights From High-Resolution Mapping. Circ Arrhythm Electrophysiol 2020 ; 13 : e008446
PubMed
P.1173 掲載の参考文献
1) Jennette JC, Falk RJ, Bacon PA, et al : 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013 ; 65 : 1-11
 
2) Grau RG : Drug-Induced Vasculitis : New Insights and a Changing Lineup of Suspects. Curr Rheumatol Rep 2015 ; 17 : 71
 
3) D'Souza A, Jaiyesimi I, Trainor L, Venuturumili P : Granulocyte colony-stimulating factor administration : adverse events. Transfus Med Rev 2008 ; 22 : 280-290
 
4) Hoshina H, Takei H : Granulocyte-colony stimulating factor-associated aortitis in cancer : A systematic literature review. Cancer Treat Res Commun 2021 ; 29 : 100454
 
5) Franzke A, Piao W, Lauber J, et al : G-CSF as immune regulator in T cells expressing the G-CSF receptor : implications for transplantation and autoimmune diseases. Blood 2003 ; 102 : 734-739
 
6) Nakamura J, Nishi TM, Yamashita S, et al : Pegfilgrastim-associated large-vessel vasculitis developed during adjuvant chemotherapy for breast cancer : A case report and review of the literature. J Oncol Pharm Pract 2020 ; 26 : 1785-1790
 
7) Miller EB, Grosu R, Landau Z : Isolated abdominal aortitis following administration of granulocyte colony stimulating factor (G-CSF). Clin Rheumatol 2016 ; 35 : 1655-1657
 
P.1175 掲載の参考文献
1) 日本乳癌学会 : 乳がん診療ガイドライン 1 治療編 2022年版. 東京 : 金原出版 ; 2022.
 
2) 岩本真佳, 寺中若菜, 片平征伸, ほか : 乳癌に対する化学療法中に発症したG-CSF製剤による薬剤性血管炎の1例. 心臓 2023 ; 55 : 1168-1173
 
3) Oshima Y, Takahashi S, Tani K, Tojo A : Granulocyte colony-stimulating factor-associated aortitis in the Japanese Adverse Drug Event Report database. Cytokine 2019 ; 119 : 47-51
 
4) Lee SY, Kim EK, Kim JY, et al : The incidence and clinical features of PEGylated filgrastim-induced acute aortitis in patients with breast cancer. Sci Rep 2020 ; 10 : 18647
PubMed
5) Takamatsu A, Yoshida K, Toshima F, et al : Single-Center Analysis of Pegfilgrastim-induced Aortitis Using a Drug Prescription Database and CT Findings. Radiology 2022 ; 305 : 729-740
 
6) 日本癌治療学会 : G-CSF適正使用ガイドライン 2022年10月改訂 第2版. 東京 : 金原出版 ; 2022.
 
P.1181 掲載の参考文献
1) Bowman AW, DiSantis DJ, Frey RT : Esophagopericardial Fistula Causing Pyopneumopericardium. Radiol Cardiothorac Imaging 2020 ; 2 : e200417
PubMed
2) 坂本英至, 長谷川洋, 小松俊一郎, ほか : 収縮性心膜炎で発症した食道心嚢瘻の1救命例. 日本腹部救急医学会雑誌 2005 ; 25 : 857-861
 
3) Gonzalez-Ojeda A, de LunaVargas MA, Nazara-Cazorla Z, et al : Esophagopericardial fistula attributed to a barogenic rupture of the esophagus. Report of a case and review of the literature. Hepatogastroenterology 2001 ; 48 : 1375-1378
 
4) Bozer AY, Saylam A, Ersoy U : Purulent pericarditis due to perforation of esophagus with foreign body. J Thorac Cardiovasc Surg 1974 ; 67 : 590-592
 
5) Choi JB, Lee SY, Jeong JW : Delayed diagnosis of purulent pericarditis caused by esophagopericardial fistula by computed tomography scan and echocardiography. Eur J Cardiothorac Surg 2001 ; 20 : 1267-1269
 
6) Kim TH, Kim SW, Seo GS, et al : Pyopneumopericardium due to an esophagopericardial fistula with a fish bone. Am J Gastroenterol 2003 ; 98 : 1441-1442
 
7) Zhu J, Zhu SB, Xi EP : Puncture of the anterior wall of the pericardium by a fish bone from an oesophageal perforation. Eur Heart J 2022 ; 43 : 2531
PubMed
8) Ormanci D, Doganay K, Ari H, et al : The way to a patient's heart is through their esophagus : A case of esophago-pericardial fistula. Echocardiography 2022 ; 39 : 1627-1630
 
9) Liao F, Zhu Z, Pan X, et al : Safety and Efficacy of Nonoperative Treatment in Esophageal Perforation Caused by Foreign Bodies. Clin Transl Gastroenterol 2022 ; 13 : e00451
PubMed
10) 市村健, 小井戸一光 : 進行食道癌治療後に発生した心嚢気腫にcovered stent留置が有用であった1例. 日本消化器病学会雑誌 2004 ; 101 : 269-273
 
P.1182 掲載の参考文献
1) Patti MG, Gantert W, Way LW : Surgery of the esophagus. Anatomy and physiology. Surg Clin North Am 1997 ; 77 : 959-970
 
2) Eitel C, Rolf S, Zachaus M, et al : Successful nonsurgical treatment of esophagopericardial fistulas after atrial fibrillation catheter ablation : a case series. Circ Arrhythm Electrophysiol 2013 ; 6 : 675-681
 
P.1189 掲載の参考文献
1) 日本循環器学会 : 2020年JCSガイドライン フォーカスアップデート版 冠動脈疾患患者における抗血栓療法. https://www.j-circ.or.jp/cms/wp-content/uploads/2020/04/JCS2020_Kimura_Nakamura.pdf (cited 2020 Apr)
 
2) 柏木浩和, 桑名正隆, 羽藤高明, ほか : 成人特発性血小板減少性紫斑病治療の参照ガイド 2019 改訂版. 臨床血液 2019 ; 60 : 877-896
 
3) 丸山園美, 井上健司, 岡井巌, ほか : 急性冠症候群を発症した特発性血小板減少性紫斑病症例に対しステント治療が成功した1例. 心臓 2009 ; 41 : 953-959
 
4) 菊池基雄, 新美達司, 山本俊幸, ほか : 経過中に心筋梗塞を併発した高齢発症特発性血小板減少性紫斑病の1例. 日本老年医学会雑誌 1996 ; 33 : 867-870
 
5) 荒木勉, 東福要平 : 急性心筋梗塞を合併した特発性血小板減少性紫斑病の1 高齢者例. 日本老年医学会雑誌 1999 ; 36 : 742-746
 
6) 菊池清香, 林豊, 藤岡精二, ほか : 急性心筋梗塞を発症しステント留置した高齢者特発性血小板減少性紫斑病の1例. 日本老年医学会雑誌 2002 ; 39 : 88-93
 
7) Fuchi T, Kondo T, Sase K, Takahashi M : Primary Percutaneous Transluminal Coronary Angioplasty Performed for Acute Myocardial Infarction in a Patient With Idiopathic Thrombocytopenic Purpura. Jpn Circ J 1999 ; 63 : 133-136
 
8) Ali EA, Rasheed M, Al-Sadi A, et al : Immune Thrombocytopenic Purpura and Paradoxical Thrombosis : A Systematic Review of Case Reports. Cureus 2022 ; 14 : e30279
 
9) British Committee for Standards in Haematology General Haematology Task Force : Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haemotol 2003 ; 120 : 574-596
 
10) Natsuaki M, Morimoto T, Yamamoto E, et al : One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus eluting cobalt-chromium stent implantation : ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial. Cardiovasc Interv Ther 2016 ; 31 : 196-209
 
11) Watanabe H, Domei T, Morimoto T, et al : Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI : The STOPDAPT-2 Randomized Clinical Trial. JAMA 2019 ; 321 : 2414-2427
 
12) Zhou X, Angiolillo DJ, Ortega-Paz L : P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention. J Cardiovasc Dev Dis 2022 ; 9 : 340
 
13) Lee CH, Kim U : Revascularization for patients with idiopathic thrombocytopenic purpura and coronary artery disease. Korean Circ J 2014 ; 44 : 264-267
 
14) Moretti C, Teresa Lucciola M, Morena L, et al : Idiopathic thrombocytopenic purpura and percutaneous coronary stenting : A dangerous duo? Int J Cardiol 2008 ; 130 : e96-97
 
15) Varghese K, Viegas M, Adhyapak SM : A therapeutic dilemma-coronary artery stenting in the setting of thrombocytopenia. Heart Lung Circ 2015 ; 24 : e214-216
 
16) Valgimigli M, Frigoli E, Heg D, et al : Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk. N Engl J Med 2021 ; 385 : 1643-1655
 
17) Watanabe H, Morimoto T, Natsuaki M, et al : Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome. The STOPDAPT-2 ACS Randomized Clinical Trial. JAMA Cardiol 2022 ; 7 : 407-417
 
18) Saito S, Isshiki T, Kimura T, et al : Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome : the PRASFIT-ACS study. Circ J 2014 ; 78 : 1684-1692
 
19) Ohya M, Shimada T, Osakada K, et al : In-Hospital Bleeding and Utility of a Maintenance Dose of Prasugrel 2.5 mg in High Bleeding Risk Patients With Acute Coronary Syndrome. Circ J 2018 ; 82 : 1874-1883
 
P.1192 掲載の参考文献
1) Lawton JS, Tamis-Holland JE, Bangalore S, et al : 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization : A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022 ; 145 : e18-e114
 
2) Byrne RA, Rossello X, Coughlan JJ, et al : 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 2023 ; 44 : 3720-3826
 
3) Levine GN, Jeong YH, Goto S, et al : Expert consensus document : World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. Nat Rev Cardiol 2014 ; 11 : 597-606
PubMed
4) Nakamura M, Kimura K, Kimura T, et al : JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease. Circ J 2020 ; 84 : 831-865
 
5) Valgimigli M, Frigoli E, Heg D, et al : Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk. N Engl J Med 2021 ; 385 : 1643-1655
 
6) Smits PC, Frigoli E, Tijssen J, et al : Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk with or without Oral Anticoagulant Therapy after Coronary Stenting : An Open-Label, Randomized, Controlled Trial. Circulation 2021 ; 144 : 1196-1211
 
7) Watanabe H, Domei T, Morimoto T, et al : Very Short Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation in Patients with High Bleeding Risk : Insight from the STOPDAPT-2 Trial. Circulation 2019 ; 140 : 1957-1959
 
P.1193 掲載の参考文献
1) Watanabe H, Domei T, Morimoto T, et al : Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI : The STOPDAPT-2 Randomized Clinical Trial. JAMA 2019 ; 321 : 2414-2427
 
2) Nakamura M, Kimura K, Kimura T, et al : JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease. Circ J 2020 ; 84 : 831-865
 
3) Watanabe H, Morimoto T, Natsuaki M, et al : Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome : The STOPDAPT-2 ACS Randomized Clinical Trial. JAMA Cardiol 2022 ; 7 : 407-417
 
4) Takeji Y, Shiomi H, Morimoto T, et al ; Demographics, practice patterns and long-term outcomes of patients with non-ST-segment elevation acute coronary syndrome in the past two decades : the CREDO-Kyoto Cohort-2 and Cohort-3. BMJ Open 2021 ; 11 : e044329
PubMed
P.1200 掲載の参考文献
1) Basman C, Pirelli L, Singh VP, et al : Lifetime management for aortic stenosis : Planning for future therapies. J Cardiol 2022 ; 80 : 185-189
 
2) 松本美富士 : 膠原病の心・肺病変とその対応. 膠原病の心病変. 日本内科学会雑誌 1996 ; 85 : 1833-1839
 
3) 朝比奈利明, 相沢一徳, 清水憲明, ほか : リウマチ結節により急性心連合弁膜症をきたした1手術例. 心臓 1988 ; 20 : 1469-1473
 
4) Roberts WC, Virmani R : Aschoff bodies at necropsy in valvular heart disease. Evidence from an analysis of 543 patients over 14 years of age that rheumatic heart disease, at least anatomically, is a disease of the mitral valve. Circulation 1978 ; 57 : 803-807
 
5) 日本循環器学会/日本胸部外科学会/日本血管外科学会/日本心臓血管外科学会 : 2020年改訂版 弁膜症治療のガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2020/04/JCS2020_Izumi_Eishi.pdf (cited 2022 May)
 
6) Goldstone AB, Chiu P, Baiocchi M, et al : Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement. N Engl J Med 2017 ; 377 : 1847-1857
PubMed
7) 天木誠, 安斉俊久 : Transcatheter Aortic Valve Implantation (TAVI) における患者スクリーニングおよび選択の重要性. 循環器専門医 2016 ; 24 : 60-66
 
8) Chiang YP, Chikwe J, Moskowitz AJ, et al : Survival and long term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years. JAMA 2014 ; 312 : 1323-1329
 
9) Takagi H, Mitta S, Ando T : Meta-analysis of Valve-in-Valve Transcatheter versus Redo Surgical Aortic Valve Replacement. Thorac Cardiovasc Surg 2019 ; 67 : 243-250
 
10) Dvir D, Webb JG, Bleiziffer S, et al : Transcatheter Aortic Valve Implantation in Failed Bioprosthetic Surgical Valves. JAMA 2014 ; 312 : 162-170
 
11) Al-Abcha A, Saleh Y, Boumegouas M, et al : Meta-Analysis of Valve-in-Valve Transcatheter Aortic Valve Implantation Versus Redo-surgical Aortic Valve Replacement in Failed Bioprosthetic Aortic Valve. Am J Cardiol 2021 ; 146 : 74-81
PubMed
12) van Steenbergen GJ, van Straten B, Lam KY, et al : Report on outcomes of valve-in-valve transcatheter aortic valve implantation and redo surgical aortic valve replacement in the Netherlands. Neth Heart J 2022 ; 30 : 106-112
 

書評

最近チェックした商品履歴

Loading...